A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease
Sign Up to like & getrecommendations! Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2200065119
Abstract: Significance Concern has increased about the pandemic potential of Nipah virus (NiV). Similar to SARS-CoV-2, NiV is an RNA virus that is transmitted by respiratory droplets. There are currently no NiV vaccines licensed for human… read more here.
Keywords: vsv vectored; recombinant vsv; vectored vaccine; virus ... See more keywords